Remibrutinib: MS Clinical Trials

4 active multiple sclerosis clinical trials involve Remibrutinib, 2 currently recruiting. The list is matched on the interventions registered at ClinicalTrials.gov, so it includes head-to-head comparisons and studies where this therapy is the comparator as well as the treatment under test.

Trial results are not treatment advice: whether a therapy is right for you depends on your type of MS, disease activity and history, which is a conversation for your neurologist.

Active Remibrutinib MS trials

MS trials by therapy